The gap at .071/.072 closed. .071 is also strong support. Surprised at the selling as the news is pivotal but TA bounce expected here. Very undervalued.
The role of CBD is getting traction for COVID even in generic form, let alone the IHL proprietary advanced compound.
- Forums
- ASX - By Stock
- IHL
- Ann: Positive Results from IHL-675 (ARDS) animal study
Ann: Positive Results from IHL-675 (ARDS) animal study, page-76
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online